Most Importance Screening Tools in Advanced Clinical Practices The Guide to Clinical Preventive Services released in 2014 comprises of updated recommendations that are intended for usage for the patient care. The recommendations are offered only as a backing for doctors making clinical resolutions concerning the health care of the patients. Therefore, these recommendations cannot be substituted for the individual decision presented by every single clinical condition by the patient’s personal doctor (Maciosek et al., 2017). As with the cases with all the clinical reference capitals, they reveal the best intellectual capacity of the discipline of medicine when they are published (Ali, Ryan, & De Silva, 2016). However, these recommendations should be utilized with the clear knowledge that continued study may result in new data and recommendations. One of the most important screening tools from these recommendations for advanced nursing practices is population screening. Through population screening, advanced nurses are able to get good data and information in their effort for the preventative health care drive (AAFP, 2017). The nurses are able to provide general education to the population being screen about the ways and importance of preventive heal care practices (Maciosek et al., 2017). They are at able to identify the at-risk patients in the populations and help them accordingly. Through population screening, advanced nurses are able to deliver health access to many people. The other importance screen tool from the recommendations is the risk assessment screening tool. The tool helps the advanced nurses to identify those patients or people who are at more risk of suffering or ailing from the particular illness under screening (Ali et al., 2016). Through risk assessment screening, the physicians are able to come up with means and ways to mitigate the occurrence of such diseases hence inhibiting its spread to other people (AAFP, 2017). Risk assessment screening creates awareness on the people more susceptible to attack by an infection or a disease. References Ali, G., Ryan, G., & De Silva, M. J. (2016). Validated screening tools for common mental disorders in low and middle income countries: a systematic review. PloS One, 11(6), 1-14. American Academy of Family Physicians [AAFP]. (2017). Summary of recommendations for clinical preventive services. Retrieved from https://www.aafp.org/dam/AAFP/documents/ patient_care/clinical_recommendations/cps- recommendations.pdf. Maciosek, M. V., LaFrance, A. B., Dehmer, S. P., McGree, D. A., Flottemesch, T. J., Xu, Z., & Solberg, L. I. (2017). Updated priorities among effective clinical preventive services. The Annals of Family Medicine, 15(1), 14-22.
Bottom of Form 1
Discussion # 2 peer post (Eduardo)
The U.S. Preventive Services Task Force (USPSTF) makes recommendations about clinical preventive services. This organization examines chains of direct and indirect evidence to demonstrate the effectiveness of a clinical preventive service. Missing links across the chains of evidence reflect gaps in the research. Common types of evidence gaps include limited evidence in primary care settings and populations, a lack of appropriate health outcomes, limited evidence linking behavior change to health outcomes, and a lack of evidence for effective preventive services in diverse populations (Mabry, et al., 2018).The USPSTF recommendations, on more than 84 preventive health services topics, are based on a systematic review of the evidence and a determination of the net balance of benefits and provides the USPSTF recommendation grades). The USPSTF aims to update and revise each recommendation regularly and considers new topics to add each year (Kurth, et al., 2018).
Population screening can make a big difference to people’s health. Individuals who are at a high risk for certain diseases can begin their medical follow-up and personalized prevention plans sooner, rather than later. Early intervention can slow or stop the progression of disease, or help prevent its development. For example, for asymptomatic adults with sustained blood pressure greater than 135/80 mm Hg the USPSTF recommends to screen for type 2 diabetes mellitus. These recommendations apply to adults with no symptoms of type 2 diabetes mellitus or evidence of possible complications of diabetes. Blood pressure measurement is an important predictor of cardiovascular complications in people with type 2 diabetes mellitus. The first step in applying this recommendation should be measurement of blood pressure (BP). Adults with treated or untreated BP >135/80 mm Hg should be screened for diabetes (Agency for Healthcare Research and Quality, 2014) .
Health risk assessment is one of the most widely used screening tools in the field of health promotion and is often the first step in multi-component health promotion programs. A health risk assessment includes a questionnaire, an assessment of health status, and personalized feedback about actions that can be taken to reduce risks, maintain health, and prevent disease. For example in high blood pressure risk assessment there are hereditary and physical risk factors such as: family history, age, gender, race. And there are modifiable risk factors such as: lack of physical activity, unhealthy diet, being overweight or obese, drinking too much alcohol, smoking, stress, etc (Agency for Healthcare Research and Quality, 2014).
Agency for Healthcare Research and Quality. (2014). A Guide to Clinical Preventive Services. Retrieved from www.ahrq.gov/sites/default/files/publications/files/cpsguide.pdf
Kurth, A., Krist, A., Borsky, A., Ciofu, L., Curry, S., Davidson, K., . . . Pignoni, M. (2018). U.S. Preventive Services Task Force Methods to Communicate and Disseminate Clinical Preventive Services Recommendations. American Journal of Preventive Medicine, 81-87. doi:10.1016/j.amepre.2017.07.004
Mabry, I., Curry, S., Phillips, W., Garcia, F., Davidson, K., & Epling, J. (2018). U.S. Preventive Services Task Force Priorities for Prevention Research. American Journal of Preventive Medicine, 54(1), 95-103. doi:10.1016/j.amepre.2017.08.014